Literature DB >> 23292779

Characterization of the MSMEG_2631 gene (mmp) encoding a multidrug and toxic compound extrusion (MATE) family protein in Mycobacterium smegmatis and exploration of its polyspecific nature using biolog phenotype microarray.

Mukti Nath Mishra1, Lacy Daniels.   

Abstract

In Mycobacterium, multidrug efflux pumps can be associated with intrinsic drug resistance. Comparison of putative mycobacterial transport genes revealed a single annotated open reading frame (ORF) for a multidrug and toxic compound extrusion (MATE) family efflux pump in all sequenced mycobacteria except Mycobacterium leprae. Since MATE efflux pumps function as multidrug efflux pumps by conferring resistance to structurally diverse antibiotics and DNA-damaging chemicals, we studied this gene (MSMEG_2631) in M. smegmatis mc(2)155 and determined that it encodes a MATE efflux system that contributes to intrinsic resistance of Mycobacterium. We propose that the MSMEG_2631 gene be named mmp, for mycobacterial MATE protein. Biolog Phenotype MicroArray data indicated that mmp deletion increased susceptibility for phleomycin, bleomycin, capreomycin, amikacin, kanamycin, cetylpyridinium chloride, and several sulfa drugs. MSMEG_2619 (efpA) and MSMEG_3563 mask the effect of mmp deletion due to overlapping efflux capabilities. We present evidence that mmp is a part of an MSMEG_2626-2628-2629-2630-2631 operon regulated by a strong constitutive promoter, initiated from a single transcription start site. All together, our results show that M. smegmatis constitutively encodes an Na(+)-dependent MATE multidrug efflux pump from mmp in an operon with putative genes encoding proteins for apparently unrelated functions.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23292779      PMCID: PMC3624517          DOI: 10.1128/JB.01724-12

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  60 in total

1.  The sequence manipulation suite: JavaScript programs for analyzing and formatting protein and DNA sequences.

Authors:  P Stothard
Journal:  Biotechniques       Date:  2000-06       Impact factor: 1.993

Review 2.  Multidrug resistance mechanisms: drug efflux across two membranes.

Authors:  H I Zgurskaya; H Nikaido
Journal:  Mol Microbiol       Date:  2000-07       Impact factor: 3.501

Review 3.  Preventing drug access to targets: cell surface permeability barriers and active efflux in bacteria.

Authors:  H Nikaido
Journal:  Semin Cell Dev Biol       Date:  2001-06       Impact factor: 7.727

4.  Na+-driven multidrug efflux pump VcmA from Vibrio cholerae non-O1, a non-halophilic bacterium.

Authors:  M N Huda; Y Morita; T Kuroda; T Mizushima; T Tsuchiya
Journal:  FEMS Microbiol Lett       Date:  2001-09-25       Impact factor: 2.742

5.  One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products.

Authors:  K A Datsenko; B L Wanner
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

6.  A multidrug efflux transporter in Listeria monocytogenes.

Authors:  M T Mata; F Baquero; J C Pérez-Díaz
Journal:  FEMS Microbiol Lett       Date:  2000-06-15       Impact factor: 2.742

7.  Role of RecJ-like protein with 5'-3' exonuclease activity in oligo(deoxy)nucleotide degradation.

Authors:  Taisuke Wakamatsu; Kwang Kim; Yuri Uemura; Noriko Nakagawa; Seiki Kuramitsu; Ryoji Masui
Journal:  J Biol Chem       Date:  2010-11-18       Impact factor: 5.157

8.  NorM of vibrio parahaemolyticus is an Na(+)-driven multidrug efflux pump.

Authors:  Y Morita; A Kataoka; S Shiota; T Mizushima; T Tsuchiya
Journal:  J Bacteriol       Date:  2000-12       Impact factor: 3.490

9.  Energy transfer between fluorescent proteins using a co-expression system in Mycobacterium smegmatis.

Authors:  I Kaps; S Ehrt; S Seeber; D Schnappinger; C Martin; L W Riley; M Niederweis
Journal:  Gene       Date:  2001-10-31       Impact factor: 3.688

10.  Efflux pump of the proton antiporter family confers low-level fluoroquinolone resistance in Mycobacterium smegmatis.

Authors:  H E Takiff; M Cimino; M C Musso; T Weisbrod; R Martinez; M B Delgado; L Salazar; B R Bloom; W R Jacobs
Journal:  Proc Natl Acad Sci U S A       Date:  1996-01-09       Impact factor: 11.205

View more
  9 in total

1.  Phenotype microarray analysis of the AdeRS two-component system in Acinetobacter baumannii.

Authors:  J-R Sun; Y-S Chiang; H-S Shang; C-L Perng; Y-S Yang; T-S Chiueh
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-07-24       Impact factor: 3.267

2.  Unique subunit packing in mycobacterial nanoRNase leads to alternate substrate recognitions in DHH phosphodiesterases.

Authors:  Rajpal Srivastav; Dilip Kumar; Amit Grover; Ajit Singh; Babu A Manjasetty; Rakesh Sharma; Bhupesh Taneja
Journal:  Nucleic Acids Res       Date:  2014-05-30       Impact factor: 16.971

3.  Characterization of a novel plasmid, pMAH135, from Mycobacterium avium subsp. hominissuis.

Authors:  Kei-ichi Uchiya; Hiroyasu Takahashi; Taku Nakagawa; Tetsuya Yagi; Makoto Moriyama; Takayuki Inagaki; Kazuya Ichikawa; Toshiaki Nikai; Kenji Ogawa
Journal:  PLoS One       Date:  2015-02-11       Impact factor: 3.240

4.  Identifying feasible metabolic routes in Mycobacterium smegmatis and possible alterations under diverse nutrient conditions.

Authors:  Priyanka Baloni; Jyothi Padiadpu; Anupam Singh; Kuldeepkumar R Gupta; Nagasuma Chandra
Journal:  BMC Microbiol       Date:  2014-11-18       Impact factor: 3.605

5.  Metabolic phenotype of clinical and environmental Mycobacterium avium subsp. hominissuis isolates.

Authors:  Andrea Sanchini; Flavia Dematheis; Torsten Semmler; Astrid Lewin
Journal:  PeerJ       Date:  2017-01-03       Impact factor: 2.984

6.  Biocide Selective TolC-Independent Efflux Pumps in Enterobacteriaceae.

Authors:  Carmine J Slipski; George G Zhanel; Denice C Bay
Journal:  J Membr Biol       Date:  2017-10-23       Impact factor: 1.843

Review 7.  New Insights in to the Intrinsic and Acquired Drug Resistance Mechanisms in Mycobacteria.

Authors:  Mohammad J Nasiri; Mehri Haeili; Mona Ghazi; Hossein Goudarzi; Ali Pormohammad; Abbas A Imani Fooladi; Mohammad M Feizabadi
Journal:  Front Microbiol       Date:  2017-04-25       Impact factor: 5.640

8.  Short, Synthetic Cationic Peptides Have Antibacterial Activity against Mycobacterium smegmatis by Forming Pores in Membrane and Synergizing with Antibiotics.

Authors:  Kajal Gupta; Sameer Singh; Monique L van Hoek
Journal:  Antibiotics (Basel)       Date:  2015-08-24

Review 9.  Efflux Pump Inhibitors Against Nontuberculous Mycobacteria.

Authors:  Laura Rindi
Journal:  Int J Mol Sci       Date:  2020-06-12       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.